The primordium that generates the embryonic posterior lateral line of zebrafish migrates from the head to the tip of the tail along a trail of SDF1-producing cells. This migration critically depends on the presence of the SDF1 receptor CXCR4 in the leading region of the primordium and on the presence of a second SDF1 receptor, CXCR7, in the trailing region of the primordium. Here we show that inactivation of the estrogen receptor ESR1 results in ectopic expression of cxcr4b throughout the primordium, whereas ESR1 overexpression results in a reciprocal reduction in the domain of cxcr4b expression, suggesting that ESR1 acts as a repressor of cxcr4b. This finding could explain why estrogens significantly decrease the metastatic ability of ESR-positive breast cancer cells. ESR1 inactivation also leads to extinction of cxcr7b expression in the trailing cells of the migrating primordium; this effect is indirect, however, and due to the down-regulation of cxcr7b by ectopic SDF1/CXCR4 signaling in the trailing region. Both ESR1 inactivation and overexpression result in aborted migration, confirming the importance of this receptor in the control of SDF1-dependent migration.
The primordium that generates the embryonic posterior lateral line of zebrafish migrates from the head to the tip of the tail along a trail of SDF1-producing cells. This migration critically depends on the presence of the SDF1 receptor CXCR4 in the leading region of the primordium and on the presence of a second SDF1 receptor, CXCR7, in the trailing region of the primordium. Here we show that inactivation of the estrogen receptor ESR1 results in ectopic expression of cxcr4b throughout the primordium, whereas ESR1 overexpression results in a reciprocal reduction in the domain of cxcr4b expression, suggesting that ESR1 acts as a repressor of cxcr4b. This finding could explain why estrogens significantly decrease the metastatic ability of ESR-positive breast cancer cells. ESR1 inactivation also leads to extinction of cxcr7b expression in the trailing cells of the migrating primordium; this effect is indirect, however, and due to the down-regulation of cxcr7b by ectopic SDF1/CXCR4 signaling in the trailing region. Both ESR1 inactivation and overexpression result in aborted migration, confirming the importance of this receptor in the control of SDF1-dependent migration.
collective cell migration | CXCR7 | FGF | SDF1 | Wnt P rogrammed cell migration plays a major role in normal development, as well as in various pathological conditions. The development of the posterior lateral line system (PLL) has recently emerged as a useful in vivo system to study collective cell migration and to elucidate the genetic network that underlies it (1) . The embryonic PLL of the zebrafish comprises seven to eight sensory organs, the neuromasts, which are sequentially deposited between head and tail tip by a migrating primordium (2, 3) . Primordium migration depends on interactions between the chemokine SDF1 (CXCL12), which is expressed along the pathway of migration, and its two receptors CXCR4 and CXCR7, which are expressed in the primordium (4) (5) (6) (7) (8) . The same three molecules have also been implicated in the migration of zebrafish germ cells (9) and facial motoneurons (10) . In mammals, SDF1/CXCR4 signaling plays a major role in the migration of several types of cancer cells, notably breast and ovary cancers.
The domains of expression of cxcr7b and of cxcr4b in the migrating PLL primordium are largely complementary, cxcr4b being expressed most intensely in the leading region, whereas cxcr7b is expressed exclusively in the trailing region (7, 8) . We have proposed that this asymmetry depends on an antagonistic interaction between the two receptors, whereby CXCR4 signaling leads to repression of cxcr7b in the leading cells, whereas CXCR7 sequestering of their common ligand, SDF1, prevents CXCR4 activation in the trailing region. This interaction would result in a gradient of CXCR4 signaling across the primordium and confer directionality to the migration (7) .
Recent studies have revealed another asymmetry in the migrating primordium. Wnt signaling takes place in the leading region and activates FGF signaling in the medial and trailing regions (11) . FGF signaling, in turn, organizes the primordium cells in rosettes that prefigure future neuromasts (12, 13) and restricts Wnt signaling to the leading cells (11) . Wnt signaling in the leading cells represses cxcr7b and has been hypothesized to activate indirectly cxcr4b in the leading region by antagonizing a putative repressor of cxcr4b (11). Here we show that the estrogen receptor ESR1 is a repressor of cxcr4b, we confirm our previous proposal that SDF1/CXCR4 signaling represses cxcr7b, and we reexamine the relation between the CXCR4/CXCR7 and the Wnt/FGF systems.
Results
To identify elements that may contribute to the control of cxcr4b expression, we studied the cxcr4b promoter region. Starting with a 6.6-kb promoter region, including the first exon and intron, that drives expression in the PLL primordium, we have been able to trim it down to a 139-bp domain, including the initiation ATG, that still allows expression in the primordium or in neuromasts in transient assays ( Fig. 1 A and B) , albeit at a relatively low level compared to the 6.6-kb promoter. A stable transgenic line expressing a membrane-bound RFP under the control of this 139-bp minimal promoter shows strong red fluorescence (Fig. 1C) nearly superimposed on the green fluorescence of the reporter line cldnb:gfp (Fig. 1D) , where all cells of the lateral line and otic systems express a membrane-bound GFP (6) . Expression of RFP is confined to the PLL, however (Fig. 1E) , showing that PLL specificity of cxcr4b expression is maintained in the 139-bp promoter. Bioinformatic analysis revealed a number of presumptive binding sites in this minimal promoter, including a putative binding site for ESR1 coupled to a Specificity Protein 1 (SP1) binding site (Fig. 1F) , a frequently found combination (14) . Comparison with the human cxcr4 promoter revealed a similar arrangement within a sequence of 157 bp just upstream of the initiation ATG (Fig. 1F) , a sequence that has been shown to allow the expression of a reporter gene in cxcr4-expressing cells (15) . Interestingly, no ESR1 binding site is present in the corresponding region of the other zebrafish CXCR4 gene, cxcr4a (Fig.  1F) , which is not expressed in the PLL primordium (16) . These data prompted us to examine whether ESR1 plays any role in controlling the migration of the primordium.
We first assessed the functional importance of ESR1 activity in PLL development by morpholino oligonucleotide inactivation of the esr1 gene. In untreated cldnb:gfp embryos, the primordium is reaching the tip of the body (somite 29/30, n = 25) at 48-hours postfertilization (hpf). In 70% of the esr1-morpholino oligonucleo- Data deposition: The sequences reported in this paper have been deposited in the GenBank database (accession nos. GU394077, GU394078, GU394079, GU394080, and GU394081). To whom correspondence should be addressed. E-mail: alain.ghysen@univ-montp2.fr. tides (MO) injected embryos, the primordium is much delayed and has only reached somite 17 ± 4 at the same age (n = 54); 48 hpf, embryos injected with a control, mismatched morpholino are negligibly different from untreated embryos (somite 29 ± 2, n = 106). To better characterize the migration defect, we followed the primordium by time lapse imaging in esr1-MO embryos. In 20 out of 28 morphant embryos, the primordium migrated at a reduced speed (1.1 somite/h in untreated cldnb:gfp embryos; Fig. 2A and Movie S1, vs 0.6 somite/h on average in morpholino-injected embryos; Fig. 2B and Movie S2). At about 40 hpf, the morphant primordium further slowed down, and eventually formed two neuromasts ( Fig. 2C and Movie S2). We conclude that esr1 is required for normal migration of the primordium.
Given the presence of a putative ESR1-binding site in the promoter region of cxcr4b, we asked whether the defective migration in esr1-MO embryos might be due to a change in the expression of cxcr4b. In control embryos, cxcr4b is expressed at a high level in the leading two-thirds of the primordium and at a much lower level in the trailing region (3) (Fig. 3A) . In 56% of esr1-MO injected embryos (n = 43), cxcr4b is clearly expressed throughout the primordium, as well as in the deposited cells (Fig. 3C) , suggesting that the expression of cxcr4b is derepressed in the trailing region.
It has been shown that constitutive activity of the Wnt/β-catenin pathway results in an extended expression of cxcr4b (11). It could be, therefore, that the derepression of cxcr4b in esr1-MO embryos (Fig. 3C ) is indirect and results from an ectopic activation of the Wnt/β-catenin in the trailing region of the primordium. We observed, however, that the expression of lef1 (a target of Wnt signaling) (11) remains restricted to the leading third of the primordium in esr1 morphant embryos, much as in untreated embryos (Fig. 3E) . We conclude that ESR1 controls cxcr4b expression independently of Wnt activity.
We confirmed that ESR1 acts as a repressor of cxcr4b expression by a gain-of-function approach. We injected mRNA coding for ESR1 in one-cell stage cldnb:gfp embryos zygotes and looked for abnormalities of primordium migration. Out of 27 injected embryos, migration was reduced by more than 50% in 23/54 sides (43%). Among the defective primordia, 16 (69%) showed severely reduced ( Fig. 3D and Fig. S1A ) or absent (Fig S1B) cxcr4b expression. Fifteen of the 16 primordia with markedly reduced cxcr4b expression had reached somite 2.1 ± 2, whereas the 31 primordia with mildly reduced or unimpaired migration had reached somite 10.0 ± 2.3 on average.
We wondered whether ESR1 is also involved in the control of cxcr7b. The expression of cxcr7b in control embryos is dynamic and may extend over the trailing one fifth of the primordium, just after neuromast deposition, to its trailing two fifths, just before deposition (Fig. 3B) . On the contrary, cxcr7b expression is not detectable in the primordium, nor in the deposited cells, in a vast majority of 30-hpf esr1-MO embryos (73%, n = 44; Fig. 3F ), showing that ESR1 is required for the proper expression of cxcr7b in the trailing cells. The absence of cxcr7b expression in esr1-MO embryos may reflect a direct requirement for ESR1, or may be a consequence of cxcr4b ectopic expression in the trailing cells. We proposed previously that SDF1/CXCR4 signaling represses cxcr7b, thereby confining the presence of CXCR7 to the trailing region of the primordium (7) . As this result has been questioned (8), we reexamined this question in cldnb:gfp embryos where the primordium can be unequivocally delimited by anti-GFP immunolabeling.
We observed that inactivation of SDF1 signaling by sdf1-MO injection results in a marked expansion of the domain of cxcr7b expression in 84% (n = 45) of the injected embryos, consistent with our previous observations (compare Fig. 3 G and H; an extreme case is shown in Fig. 3I and the case of a primordium migrating along an ectopic path, and therefore in complete absence of SDF1, is shown Fig. S2B ). In all cases, the change in cxcr7b expression was accompanied by severe impairment of migration. The expanded domain of cxcr7b expression never included the anteriormost cells of the primordium, however, suggesting that some other factor, possibly Wnt signaling, can repress cxcr7b independently of SDF1/CXCR4 signaling.
We then examined whether the effect of esr1 inactivation on cxcr7b expression is due to cxcr4b ectopic expression. If the downregulation of cxcr7b in the trailing region of esr1-MO embryos results from ectopic SDF1/CXCR4 signaling, inactivation of sdf1 or cxcr4b should reverse the effect of esr1 inactivation. One would therefore expect to see a rescue of cxcr7b expression in esr1-MO, sdf1-MO and in esr1-MO, cxcr4b-MO3 double morphant embryos, or in esr1-MO, ody -embryos, where cxcr4b is mutated (17) . If, on the other hand, ESR1 were directly required for cxcr7b expression, then embryos that lack both ESR1 and SDF1, or ESR1 and CXCR4 activity should lack cxcr7b expression, much like in the single esr1-MO condition. To ensure that the results were not biased by the presence of nonmorphant embryos, we assessed the expression domain of cxcr7b only in embryos that showed an altered migration. We observed a rescue of cxcr7b expression in 81% of esr1-MO, sdf1-MO embryos (n = 42) that showed altered migration of the primordium (compare Fig. 3 J to F) . This rescue demonstrates that the absence of ESR1 indirectly represses cxcr7b. The expression of cxcr7b reached the anterior half of the primordium in 38% of the embryos (Fig. 3J) . A similar rescue was obtained in 87% of esr1-MO, ody − embryos (n = 28; Fig. 3K) , with an expanded domain of cxcr7b expression in 14% of the embryos. Rescue of cxcr7b expression was also observed in 36% of esr1-MO, cxcr4b-MO3 embryos (n = 32; Fig. 3L) , with an expanded cxcr7b domain in 16% of the embryos. Altogether, the results clearly show that ectopic SDF1/CXCR4 signaling is responsible for the extinction of cxcr7b expression in the trailing region of esr1-MO primordia.
We examined whether the asymmetry in the expression of cxcr4b and cxcr7b may be further enhanced by positive feedback of SDF1/ CXCR4 signaling on cxcr4b expression. We observed in 69% of the cases (n = 45) a marked reduction of the domain of cxcr4b expression in sdf1-MO embryos (compare Fig. 3 M to A) . A decrease in the expression of cxcr4b was also observed in ody − mutant embryos, where cxcr4b is mutationally inactivated (Fig. 3N) . Interestingly, even when the primordium migrates away from its normal path in sdf1-MO embryos, ensuring that no residual SDF1 activity can be invoked, cxcr4b is still expressed in a leading domain where cxcr7b expression is prevented (Fig. S2A) . The leading domain, where the expression of cxcr4b is maintained in the absence of SDF1/CXCR4 signaling ( Fig. 3 M and N) , and where cxcr7b expression is prevented even in the absence of SDF1/ CXCR4 (Fig. 3 H-J) , appears similar to the domain of lef1 expression (Fig. 3E) , suggesting that expression of cxcr4b in the leading cells (and repression of cxcr7b in the same cells) may be under direct control of Wnt signaling.
The down-regulation of cxcr4b in the trailing region, but not in the leading two-thirds of the primordium, could reflect a localized expression of esr1 in the trailing cells. This is not the case: in situ hybridization reveals that esr1 is weakly but homogeneously expressed throughout the primordium (Fig. 3 O and P) . Two alternative mechanisms can account for the coexpression of the repressor gene esr1 and of its target cxcr4b in the leading cells: either ESR1 needs a corepressor, which itself is only present, or active, in the trailing region, or else the repression by ESR1 is counteracted by an activating mechanism in the leading region.
Finally, we examined whether the effect of ESR1 on cxcr4b expression is direct or indirect, by examining the expression of rfp driven by the cxcr4b promoter in the presence of an excess of ESR1. One of three stable transgenic lines for the 139-bp-rfp construct shows fluorescence in the entire primordium and in deposited cells (Fig. 1C) , and we verified by in situ hybridization that rfp is also expressed throughout the primordium in this line. Another two stable transgenic lines only produced weak fluorescence and no mRNA detectable by in situ hybridization, making it impossible to decide whether the ubiquitous expression shown Fig. 1C is due to an inefficient ESR1 binding site (presumably due to the lack of all 5′ flanking sequences) (Fig. 1F) or to overexpression induced by surrounding sequences. Because the putative ESR1 binding site of the 139-bp promoter may not be fully functional, we decided to use the 250-bp promoter (same 3′ end as the 139-bp minimal promoter) to drive rfp expression in transient assays.
We first determined whether the coinjection of esr1 mRNA with the 250-bp-rfp construct would affect rfp expression. We found that, whereas 50% (n = 140) of the embryos injected with the construct alone express rfp in the migrating primordium (Fig. S3A) , the proportion of cases where rfp is not expressed increases from 50 to 84% (n = 70) in embryos coinjected with the construct and with esr1 mRNA (Fig. S3B) . This difference is highly significant (P = 0.003, X 2 test) and indicates that ESR1 does repress transcription controlled by the 250-bp cxcr4b promoter. We then repeated the experiment using a 250-bp promoter that had been mutated for the putative recognition site of ESR1. In this case, the proportion of positive primordia was 46% (n = 128) in embryos injected with the plasmid alone and 34% (n = 80) when the construct was coinjected with esr1 mRNA, a marginal difference (P = 0.52, X 2 test). Because the marked repression of the 250-bp promoter by ubiquitous ESR1 activity is largely if not fully reversed when the putative ESR1 binding site within the 250-bp promoter is mutated, we conclude that ESR1 acts directly on this promoter.
Discussion
We showed that a fragment of 139 bp upstream of and including the cxcr4b initiation ATG specifically directs the expression of a reporter gene in the migrating PLL primordium but not in anterior lateral line components. This sequence comprises at its 3′ end a binding site for the estrogen receptor ESR1. This binding site may not be sufficient for full repression of cxcr4b because we observed in a stable transgenic line, that the reporter gene keeps being expressed in the trailing cells where endogenous cxcr4b is turned off. Nevertheless we showed that the addition of ESR1 mRNA decreases the expression of a reporter gene driven by a slightly larger (250 bp) fragment and that this effect is reversed when the ESR1 binding sequence is mutated. The relative inefficiency of this binding site in the stable transgenic line could be due either to the position of the binding site at the 3′ end of the 139-bp promoter sequence, or else to the existence of additional factors that bind to sites not included in this 139-bp fragment and contribute to repression of cxcr4b. In either case, the high levels of ESR1 provided by mRNA injection may be sufficient to bring suppression in spite of the absence of additional sequences or factors.
The existence of antagonistic interactions between CXCR4 and CXCR7 (7) has been questioned based on an analysis of ody − embryos, where the cxcr4b gene is inactivated (8) . The present results establish beyond doubt that the ectopic expression of cxcr4b in the trailing region of the PLL primordium, in esr1-MO embryos, is accompanied by a complete repression of cxcr7b in this region, and that this repression is due to SDF1/CXCR4 signaling. The most obvious explanation for the difference between our previous results and those of Valentin et al. (8) would be the presence of residual CXCR4 activity in their mutant or morphant conditions either because the ody − mutation is not an amorph, or because of some compensatory mechanism, possibly involving the cxcr4a gene. CXCR4 activity is required for targeting the germ cells to the gonads (18) , yet homozygous ody − adults are fertile, although at a low level, suggesting that the ody − mutation does not behave as an amorph. The cxcr4b morpholino that Valentin et al. (8) used, and the one we used previously (4), both directed against the initiation codon, have irregular effects in our hands, possibly depending on differences in genetic background. The morpholino that we used in the present study (antisplice) gives us more consistent results. Whatever the reason for previous differences in results, we believe that the present study demonstrates that CXCR4 activity can repress cxcr7b.
Based on our results, we propose a dual control for cxcr4b expression and subsequently for cxcr7b expression and primordium migration (Fig. 4) . One level of control of primordium migration is the direct repression of cxcr4b by ESR1 in the trailing cells, resulting in cxcr7b expression in these cells, primordium asymmetry and directional migration. The stability of this level of control is reinforced by the positive feedback that SDF1/CXCR4 signaling exerts on cxcr4b expression. The second level of control depends on the Wnt/FGF polarization of the primordium. Wnt activity in the leading cells results in repression of cxcr7b (11) and possibly in activation of cxcr4b (as suggested by the similarity between the domains of Wnt activity/lef1 expression and the domains where cxcr4b remains expressed and cxcr7b remains repressed in the absence of CXCR4 signaling). Whether ESR1, or a cofactor, are themselves under the control of Wnt signaling, and therefore correspond to the "trailing repressor" hypothesized by Aman and Piotrowski (11), remains to be determined.
The observation that ESR1 acts as a repressor of cxcr4b is intriguing, as it is well established that CXCR4 is involved in breast cancer metastasis (19) . The paradoxical finding that estrogens stimulate the growth of ESR-positive breast cancer cells and at the same time significantly decrease their metastatic ability (20) would be explained if ESR1 acts as a repressor of cxcr4 in humans, as it does in zebrafish. Another estrogen receptor, ESR2b (Erβ2), plays a role in the development of the lateral line system at a later step, the formation of hair cells within the neuromasts. ESR2b is present in the cells that surround the hair cells, but not in the latter, and seems to down-regulate Notch, thereby allowing the formation of hair cells progenitor cells (21) . We do not know if the implication of two estrogen receptors at different stages of lateral line development is a simple coincidence or has some historical or physiological explanation.
The control of primordium organization and migration by two self-maintained, connected systems, Wnt/FGF on one hand and CXCR4/CXCR7 on the other hand, would ensure a remarkable stability of the migration process and may explain the extreme conservation of embryonic PLL patterns across all teleosts, from the relatively basal zebrafish to highly derived flatfish embryos (22) . This duality may also explain why, whereas the inactivation of SDF1, CXCR4, or CXCR7 prevents migration altogether, interfering with the other components of this control system (Wnt, FGF, ESR1) only leads to reduced migration, which eventually comes to a halt after several hours (11) (12) (13) .
Materials and Methods
Fish Strain. All experiments were performed in the cldnb:gfp reporter line, except for the analysis of cxcr4b and cxcr7b expression in the ody − line. Both the cldnb:gfp and the homozygous ody − line were provided by D. Gilmour, EMBL, Heidelberg, Germany. Although the migration of the primordium is always altered in ody − embryos, we observed in pair matings that the severity of the phenotype (position of the primordium before it stops) varies from pair to pair. We selected for the experiments the pair that gave the highest proportion of nonmigrating primordia. Ages are expressed as hpf.
Identification of a Minimal cxcr4b Promoter. A 6.6-kb promoter fragment, including the first exon with the ATG start codon and the first intron, was amplified by PCR using primers zCXP2 (AAGGCCTGTCACAGCTCATTGCATGTT) and zCXE2N (TTATAGCGGCCGCGTCTAAAATGATGCTCTGCAGAA), phosphorylated, digested with NotI, and inserted in a Tol-2 derived vector ahead of an ORF encoding a membrane version of mCherry (RFP) (23) Morpholino Injection. Antisense MO were obtained from Gene Tools, diluted in water containing 5% phenol red, and injected in one-cell stage embryos. For the knockdown of esr1, a 5′UTR morpholino (5′GGAAGGTTCCTCCAGGGCTTCTC-TC3′) was injected at a concentration of 0.35 mM to provide the best combination of survival (90%) and phenotype. sdf1-MO was used at a concentration of 1.25 mM instead of 0.5 mM as described previously (4). The two cxcr4b-MO oligonucleotides published previously (4, 8) , both directed against the initiation ATG, gave inconsistent results in the two lines used for the present work, possibly related to differences in genetic background with the commercially available golden line used previously (4). We designed a third morpholino, cxcr4b-MO3, against the splice site, 5-TTAATCACAAGCCAACTTACATCGT-3′. When used at 3 mM, this morpholino induces low lethality (11%) and a reliable PLL phenotype. When two morpholinos were injected simultaneously, each was injected at its working concentration. The esr1 control morpholino had five mismatches: 5′ GCAAGCTTCCTGCAGGCCTTCTGTC3′.
Time-Lapse Imaging. cldnb:gfp embryos were anesthetized in 0.01% tricaine methanesulfonate (Sigma) and embedded in 0.5% agar. Time-lapse analyses were performed on an Axioimager M1 Zeiss Microscope equipped with a 20× long distance, water-immersion objective, and a CoolSnap camera. Embryos were maintained at 26°C by a stage heating device (Pecon Gmbh), and Z stacks of 10 frames 10-μm apart, to allow for changes in focal plane due to fish development, were collected at intervals of 10 min.
Whole Mount in Situ Hybridization. The 32-hpf embryos were processed for in situ hybridization as described by Westerfield (24) . The hybridized probe was detected using an alkaline phosphatase-coupled antidioxygenin antibody (1:2,000; Roche). The esr1 probe was prepared as follows: the primers AGA-ATCGAGTGCCGCTGTAT and GAGGAAATCAGAGCAGCGTT were used to amplify part of the 3′ untranslated region of the esr1 cDNA. The PCR product was cloned in the pZERO-2 vector (Invitrogen) and used as a template to generate the RNA probes. Both antisense and sense digoxygenin-labeled probes were synthesized using SP6 or T7 RNA polymerase (Roche), respectively, and purified with a RNA purification kit (Macherey-Nagel). The sense probe showed no specific labeling. We also used digoxygenin-labeled riboprobes for the detection of cxcr4b and cxcr7b (7), and of lef1 (25) . The esr1 probe was used at a concentration of 150-200 ng/500 μL, the other probes were used at 500 ng/ 500 μL. Stained embryos were mounted in 100% glycerol and photographed on a Zeiss Axioplan microscope equipped with a Canon G5 camera. Fig. 4 . Control of expression of cxcr4b and cxcr7b in the leading (Right) and trailing (Left) regions of the migrating primordium. The expression of cxcr4b, which is homogeneous before the onset of migration (7), is repressed in the trailing third by ESR1, and maintained in the leading two-thirds by positive feedback through SDF1/CXCR4 signaling. An additional activating mechanism, possibly under direct control of Wnt signaling, ensures expression of cxcr4b in the leading cells even in the absence of CXCR4 signaling. The complementary pattern of expression for cxcr7b reflects repression by SDF1/CXCR4 signaling and an additional repression by Wnt signaling in the leading cells (11 
